KR920019784A - 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 - Google Patents
벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 Download PDFInfo
- Publication number
- KR920019784A KR920019784A KR1019920007140A KR920007140A KR920019784A KR 920019784 A KR920019784 A KR 920019784A KR 1019920007140 A KR1019920007140 A KR 1019920007140A KR 920007140 A KR920007140 A KR 920007140A KR 920019784 A KR920019784 A KR 920019784A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- hydrogen
- formula
- lower alkyl
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (11)
- 일반식 (I)의 화합물, 이의 기하 및 광학 이성체 또는 약제학적으로 허용되는 이의 염.상기식에서, R1은 수소 또는 저급 알킬이고, R2는 저급 알킬이거나,그룹이고, R3은 수소 또는 저급 알킬이고, A는 저급 알킬렌이거나, 일반식 -CHR4CH=CHCHR4-또는-CHR4C=CHR4-의 그룹이고, R4는 수소 또는 저급 알킬이고, R4는 수소 또는 저급 알킬이고, X는 O또는 S이고, W는 N 또는 CH이고, Y는 수소, 저급 알킬, 저급 알콕시, 하이드록시, 할로겐 또는 트리플루오로메틸이고, Z는 수소, 저급 알킬, 저급 알콕시, 하이드록시, 할로겐 또는 트리플루오로메틸이고, n은 1 또는 2이며, 실선(-)은 일반식의 지시된 원소에 대한 그룹의 부착점을 나타낸다.
- 제1항에 있어서, Y가 수소이고 Z는 수소, 저급 알콕시 또는 할로겐이며 n이 1인 화합물.
- 제2항에 있어서, X가 S이고 A가 C1-C4알킬렌이며 R2가 일반식.〔여기서, Z는 수소, 메톡시 또는 플루오로이다〕의 그룹인 화합물.
- 제1항에 있어서, N-메틸-N-〔4-(1-(2-메톡시페닐)-4-피페라지닐)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-메틸-N-〔4-(1-(6-플로오로벤조〔b〕티오펜-3-일)-4-피페라진-일)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-메틸-N-〔4-(1-(6-플로오로-1,2-벤조이소옥사졸-3-일)-4-피페라진-일)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-〔2-(1-(4-플루오로벤조일-4-피페라지닐)에틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 제1항에 있어서, N-메틸-N-〔4-(1-(1,2-벤조이소옥사졸-3-일)-4-피페라진-일)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
- 활성 성분으로서 제1항에서 정의한 바와 같은 화합물 및 이의 적합한 담체를 포함하는 약제학적 조성물.
- 항정신병적 활성을 갖는 약제를 제조하기 위한 제1항의 화합물의 용도.
- a)일반식(I)의 화합물을 일반식(2)의 화합물과 반응시키거나, b)일반식(3)의 화합물을 일반식(2a)의 화합물과 반응시킴을 포함하는, 제1항의 화합물의 제조방법.상기식에서, R1, R2, A, X, Y, W 및 n은 제1항에서 정의한 바와 같고, R1은 클로로, 브로모 또는 요오도이거나, 그를 OSO2R6〔여기서, R6은 알킬, 페닐 또는 톨릴이다〕이며, Hal은 클로로 또는 브로모이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/693,168 | 1991-04-29 | ||
US7/693,168 | 1991-04-29 | ||
US90/002891A US5143923B1 (en) | 1991-04-29 | 1991-04-29 | Benzoisothiazole-and benzisoxazole-3-carboxamides |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920019784A true KR920019784A (ko) | 1992-11-20 |
KR100215345B1 KR100215345B1 (ko) | 1999-08-16 |
Family
ID=24783602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920007140A KR100215345B1 (ko) | 1991-04-29 | 1992-04-28 | 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5143923B1 (ko) |
EP (1) | EP0511610B1 (ko) |
JP (1) | JP2656189B2 (ko) |
KR (1) | KR100215345B1 (ko) |
AT (1) | ATE142628T1 (ko) |
AU (1) | AU644054B2 (ko) |
CA (1) | CA2067404C (ko) |
CZ (1) | CZ282764B6 (ko) |
DE (1) | DE69213544T2 (ko) |
DK (1) | DK0511610T3 (ko) |
ES (1) | ES2094843T3 (ko) |
FI (1) | FI921875A (ko) |
GR (1) | GR3021211T3 (ko) |
HU (1) | HU214032B (ko) |
IE (1) | IE77036B1 (ko) |
IL (1) | IL101700A (ko) |
MX (1) | MX9201963A (ko) |
NO (1) | NO180488C (ko) |
NZ (1) | NZ242479A (ko) |
PL (2) | PL168870B1 (ko) |
RU (1) | RU2039057C1 (ko) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378714A (en) * | 1991-11-27 | 1995-01-03 | Novo Nordisk A/S | Antipsychotic piperidine derivatives |
SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
US5240927A (en) * | 1992-05-19 | 1993-08-31 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzo[β]thiophen-3-yl piperazines as antipsychotic agents |
US5272148A (en) * | 1992-09-09 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Heteroarenylpiperazines |
GB9302622D0 (en) * | 1993-02-10 | 1993-03-24 | Wellcome Found | Heteroaromatic compounds |
GB9501865D0 (en) * | 1995-01-31 | 1995-03-22 | Merck Sharp & Dohme | Therapeutic agents |
GB9603457D0 (ko) * | 1996-02-19 | 1996-04-17 | Merck & Co Inc | |
US5952351A (en) * | 1995-02-23 | 1999-09-14 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
US6096763A (en) * | 1995-02-23 | 2000-08-01 | Merck & Co., Inc. | α1a adrenergic receptor antagonists |
SK281879B6 (sk) * | 1995-02-28 | 2001-08-06 | H. Lundbeck A/S | 4-aminotetrahydrobenzizoxazolové alebo -izotiazolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie |
ES2170177T3 (es) * | 1995-03-17 | 2002-08-01 | Aventis Pharma Inc | Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion. |
GB9716101D0 (en) * | 1997-07-30 | 1997-10-01 | Pharmacia & Upjohn Spa | Fused heterocyclic compounds |
IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
US6339087B1 (en) * | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
PT1131291E (pt) * | 1998-11-17 | 2005-01-31 | Hoffmann La Roche | Antagonistas iii do receptor 4-aroil-piperidin-ccr-3 |
KR20010081034A (ko) | 1998-11-20 | 2001-08-25 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 피페리딘 씨씨알-3 수용체 길항제 |
JP2002540204A (ja) * | 1999-03-26 | 2002-11-26 | アストラゼネカ・アクチエボラーグ | 新規化合物 |
US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
US7253165B2 (en) | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
TWI306859B (en) | 2000-04-28 | 2009-03-01 | Acadia Pharm Inc | Muscarinic agonists |
EP1535912A1 (en) * | 2000-04-28 | 2005-06-01 | Arcadia Pharmaceuticals Inc. | Muscarinic agonists |
GB0013060D0 (en) * | 2000-05-31 | 2000-07-19 | Astrazeneca Ab | Chemical compounds |
GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
EP1935887B1 (en) | 2001-02-16 | 2010-01-13 | Aventis Pharmaceuticals, Inc. | Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
GB0117899D0 (en) * | 2001-07-23 | 2001-09-12 | Astrazeneca Ab | Chemical compounds |
SE0102809D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | Novel compounds |
CA2498936C (en) * | 2002-09-14 | 2013-02-12 | Gov't Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Structurally rigid dopamine d3 receptor selective ligands and process for making them |
OA12923A (en) * | 2002-09-17 | 2006-10-13 | Warner Lambert Co | Heterocyclic substituted piperazines for the treatment of schizophrenia. |
US20040127501A1 (en) * | 2002-09-24 | 2004-07-01 | Zhengming Chen | Therapeutic agents useful for treating pain |
KR20060061393A (ko) * | 2003-10-24 | 2006-06-07 | 에프. 호프만-라 로슈 아게 | Ccr3 수용체 길항제 |
US20160296146A9 (en) * | 2006-06-29 | 2016-10-13 | Fred Wood | Apparatus-Mounted Vein Contrast Enchancer |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2626260A (en) * | 1951-09-05 | 1953-01-20 | Sterling Drug Inc | Nitrobenzisoxazoles |
US3145215A (en) * | 1961-12-19 | 1964-08-18 | Sterling Drug Inc | Indazole derivatives |
US3576810A (en) * | 1968-06-20 | 1971-04-27 | Robins Co Inc A H | 1-substituted-3-(-4)-aroylpiperidines |
US4021552A (en) * | 1975-06-27 | 1977-05-03 | A. H. Robins Company, Incorporated | 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES |
US4327103A (en) * | 1980-07-07 | 1982-04-27 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-{3-[4-(4-Fluorobenzoyl)piperidyl]propyl}-2-methyl indole |
US4452799A (en) * | 1981-12-23 | 1984-06-05 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
IL66866A (en) * | 1982-04-09 | 1987-08-31 | Hoechst Roussel Pharma | 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them |
DK169601B1 (da) * | 1983-10-17 | 1994-12-19 | Duphar Int Res | Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse |
CH667657A5 (de) * | 1985-01-07 | 1988-10-31 | Sandoz Ag | Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine. |
JPS61219950A (ja) * | 1985-03-26 | 1986-09-30 | Fuji Photo Film Co Ltd | 熱現像感光材料 |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
GB8623142D0 (en) * | 1986-09-26 | 1986-10-29 | Beecham Group Plc | Compounds |
DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | Hoffmann La Roche | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
FR2616149B1 (fr) * | 1987-06-04 | 1990-10-19 | Adir | Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent |
DE3827253A1 (de) * | 1987-08-20 | 1989-03-02 | Sandoz Ag | Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen |
US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
CA1340113C (en) * | 1988-05-24 | 1998-11-03 | Magid A. Abou-Gharbia | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
US5114936A (en) * | 1990-08-23 | 1992-05-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use |
-
1991
- 1991-04-29 US US90/002891A patent/US5143923B1/en not_active Expired - Fee Related
-
1992
- 1992-04-08 CA CA002067404A patent/CA2067404C/en not_active Expired - Fee Related
- 1992-04-24 NZ NZ242479A patent/NZ242479A/en unknown
- 1992-04-27 IL IL10170092A patent/IL101700A/en not_active IP Right Cessation
- 1992-04-27 EP EP92107138A patent/EP0511610B1/en not_active Expired - Lifetime
- 1992-04-27 ES ES92107138T patent/ES2094843T3/es not_active Expired - Lifetime
- 1992-04-27 PL PL92309056A patent/PL168870B1/pl unknown
- 1992-04-27 PL PL92294358A patent/PL168090B1/pl unknown
- 1992-04-27 AT AT92107138T patent/ATE142628T1/de not_active IP Right Cessation
- 1992-04-27 DK DK92107138.7T patent/DK0511610T3/da active
- 1992-04-27 FI FI921875A patent/FI921875A/fi not_active IP Right Cessation
- 1992-04-27 DE DE69213544T patent/DE69213544T2/de not_active Expired - Fee Related
- 1992-04-28 JP JP4108229A patent/JP2656189B2/ja not_active Expired - Fee Related
- 1992-04-28 CZ CS921298A patent/CZ282764B6/cs not_active IP Right Cessation
- 1992-04-28 NO NO921654A patent/NO180488C/no unknown
- 1992-04-28 MX MX9201963A patent/MX9201963A/es not_active IP Right Cessation
- 1992-04-28 KR KR1019920007140A patent/KR100215345B1/ko not_active IP Right Cessation
- 1992-04-28 RU SU925011480A patent/RU2039057C1/ru active
- 1992-04-28 AU AU15187/92A patent/AU644054B2/en not_active Ceased
- 1992-04-29 HU HU9201414A patent/HU214032B/hu not_active IP Right Cessation
- 1992-07-01 IE IE921379A patent/IE77036B1/en not_active IP Right Cessation
-
1996
- 1996-09-30 GR GR960402568T patent/GR3021211T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920019784A (ko) | 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 | |
KR910006277A (ko) | N-치환된-4-피리미딘아민 및 피리미딘디아민, 이의 제조방법 및 약제로서의 이의 용도 | |
RU96115142A (ru) | Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов | |
KR890003742A (ko) | 카르바모일키롤리돈 유도체 및 노인성 치매용 약제 | |
KR890005095A (ko) | 신규 화합물들 | |
DK0628311T3 (da) | Xanthinderivater som antidepressive midler | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
DE69725113D1 (de) | Azetidin- und Pyrrolidinderivate | |
KR840006633A (ko) | 벤족사졸리논 유도체의 제조방법 | |
DK163288D0 (da) | 2-(4-(4-(4-((2-(2,4-difluorphenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)triazoloner | |
KR920021493A (ko) | 페녹시페닐 유도체 | |
DE69111816T4 (de) | Indolederivate und ihre verwendung als serotonin-antagoniste. | |
AU2003269923A8 (en) | 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors | |
DK132188D0 (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
KR960007592A (ko) | 신규한 피롤로카바졸 | |
DE69015384T2 (de) | Ringsubstituierte 2-Amino-1,2,3,4-Tetrahydro-naphthaline und 3-Aminochromane. | |
PE20050587A1 (es) | Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales | |
KR920016452A (ko) | N-(아릴옥시알킬)헤테로아릴-8-아자비시클로[3.2.1]옥탄, 중간체, 이의 제조방법 및 약제로서 이의 용도 | |
KR880003920A (ko) | 피리다지논 유도체 | |
DK0506434T3 (da) | Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler | |
JP2002514623A5 (ko) | ||
KR910020007A (ko) | 3-[1-티아졸리디닐부틸-4-피페라지닐]-1h-인다졸, 이의 제조방법 및 이의 약제로서의 용도 | |
KR940005621A (ko) | 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도 | |
FI914219A (fi) | 3-(1h-indazol-3-yl)-4-pyridinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel. | |
DE69002340T2 (de) | Pyrimidin-Derivate, 2-[4-(Alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl] mit serotoninergischer Wirkung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030519 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |